JP3520149B2 - External preparation for skin roughening - Google Patents
External preparation for skin rougheningInfo
- Publication number
- JP3520149B2 JP3520149B2 JP35182395A JP35182395A JP3520149B2 JP 3520149 B2 JP3520149 B2 JP 3520149B2 JP 35182395 A JP35182395 A JP 35182395A JP 35182395 A JP35182395 A JP 35182395A JP 3520149 B2 JP3520149 B2 JP 3520149B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- acid
- external preparation
- poe
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 77
- 238000007788 roughening Methods 0.000 title description 2
- -1 aminoethyl compound Chemical class 0.000 claims description 69
- 229960000401 tranexamic acid Drugs 0.000 claims description 22
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 8
- 238000013329 compounding Methods 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims description 4
- 210000003491 skin Anatomy 0.000 description 108
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 50
- 230000000694 effects Effects 0.000 description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- 239000003921 oil Substances 0.000 description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 25
- 239000000284 extract Substances 0.000 description 25
- 235000019198 oils Nutrition 0.000 description 25
- 235000014113 dietary fatty acids Nutrition 0.000 description 24
- 239000000194 fatty acid Substances 0.000 description 24
- 229930195729 fatty acid Natural products 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 15
- 235000019388 lanolin Nutrition 0.000 description 15
- 229940039717 lanolin Drugs 0.000 description 15
- 239000000843 powder Substances 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 229960005150 glycerol Drugs 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 12
- 235000019438 castor oil Nutrition 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 12
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000002156 mixing Methods 0.000 description 9
- 235000013772 propylene glycol Nutrition 0.000 description 9
- 229960004063 propylene glycol Drugs 0.000 description 9
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 6
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 235000015424 sodium Nutrition 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000017788 Cydonia oblonga Nutrition 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- FERWBXLFSBWTDE-UHFFFAOYSA-N 3-aminobutan-2-ol Chemical compound CC(N)C(C)O FERWBXLFSBWTDE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229940113165 trimethylolpropane Drugs 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920000569 Gum karaya Polymers 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 241000934878 Sterculia Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 2
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000010494 karaya gum Nutrition 0.000 description 2
- 239000000231 karaya gum Substances 0.000 description 2
- 229940039371 karaya gum Drugs 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N o-aminobenzenecarboxylic acid Natural products NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229910052628 phlogopite Inorganic materials 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- FCAXDVKLWVSHGT-KVVVOXFISA-N (z)-docos-13-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O FCAXDVKLWVSHGT-KVVVOXFISA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- TWMYHPDDNIOLKP-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO TWMYHPDDNIOLKP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- OQCQSNQEGNRYKL-UHFFFAOYSA-N 2-aminoethanesulfinic acid Chemical compound NCCS(O)=O.NCCS(O)=O OQCQSNQEGNRYKL-UHFFFAOYSA-N 0.000 description 1
- ICFRVXBXPFMEST-UHFFFAOYSA-N 2-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(CCCC)C(=O)C1=CC=CC=C1 ICFRVXBXPFMEST-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- CKGQJOFAVYEVFG-KXQOOQHDSA-N 2-fluoro-4-[[(1R)-6-[2-[4-[1-(4-methoxyphenyl)-5-methyl-6-oxopyridazin-3-yl]triazol-1-yl]ethoxy]-1-methyl-1-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,4-dihydro-2H-isoquinolin-7-yl]oxy]benzoic acid Chemical compound COc1ccc(cc1)-n1nc(cc(C)c1=O)-c1cn(CCOc2cc3CCN[C@](C)(CC(=O)Nc4nccs4)c3cc2Oc2ccc(C(O)=O)c(F)c2)nn1 CKGQJOFAVYEVFG-KXQOOQHDSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- WDMFHQNUSVLQMS-UHFFFAOYSA-N 5-(3,3-dimethyl-2-bicyclo[2.2.1]heptanylidene)pent-3-en-2-one Chemical compound C1CC2C(C)(C)C(=CC=CC(=O)C)C1C2 WDMFHQNUSVLQMS-UHFFFAOYSA-N 0.000 description 1
- CEZCNYWZERNMMR-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid diphenylmethanone Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=CC=C1.OC1=C(C=C(C(=O)C2=CC=CC=C2)C=C1)C(=O)O CEZCNYWZERNMMR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000370685 Arge Species 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- DFERZTIWCDQJHJ-AXDSSHIGSA-N CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO Chemical compound CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO DFERZTIWCDQJHJ-AXDSSHIGSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241001166994 Kummerowia striata Species 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910017625 MgSiO Inorganic materials 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003918 blood extract Substances 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- HBHZKFOUIUMKHV-UHFFFAOYSA-N chembl1982121 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HBHZKFOUIUMKHV-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- TXYWCMKJMWCBKE-UHFFFAOYSA-N ethyl 3-(1,4-dimethoxycyclohexa-2,4-dien-1-yl)prop-2-enoate Chemical compound CCOC(=O)C=CC1(OC)CC=C(OC)C=C1 TXYWCMKJMWCBKE-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- VVNRQZDDMYBBJY-UHFFFAOYSA-M sodium 1-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21 VVNRQZDDMYBBJY-UHFFFAOYSA-M 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000626 sulfinic acid group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- IFYFNVDTVZKNBZ-UHFFFAOYSA-N tetradecyl 2-hydroxybenzoate Chemical compound CCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1O IFYFNVDTVZKNBZ-UHFFFAOYSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚外用剤に関す
る技術分野に属する。より詳しくは、肌荒れ改善効果が
著しく向上した皮膚外用剤に関する。TECHNICAL FIELD The present invention belongs to a technical field relating to a skin external preparation. More specifically, the present invention relates to a skin external preparation having a significantly improved rough skin improving effect.
【0002】[0002]
【従来の技術】美肌状態を維持する機能の付与は、化粧
品等の皮膚外用剤を開発する際の非常に大きな目的の一
つである。この美肌状態を保つためには、肌荒れを防止
又は改善して、肌の皮溝、皮丘を整えることが重要であ
る。2. Description of the Related Art The imparting of a function of maintaining a beautiful skin condition is one of the most important purposes when developing a skin external preparation such as cosmetics. In order to maintain this beautiful skin condition, it is important to prevent or improve the roughness of the skin and prepare the skin groove and crest.
【0003】従来より、美肌状態の維持を目的として、
皮膚に水分と油分とを補給するクリームや乳液がスキン
ケア基剤として用いられてきた。そして、様々な皮膚外
用剤に、各種の保湿剤が積極的に配合されるに至ってい
る。しかしながら、現在汎用されている保湿剤であるグ
リセリン,ソルビトール,プロピレングリコールやマル
チトール等は、多量に配合するとべたついたり、ほてっ
た感覚を伴う傾向が強い。また、DL−スレオニン等の
アミノ酸系の保湿剤は、着色や変臭等の欠点を有する傾
向がある。Conventionally, for the purpose of maintaining a beautiful skin condition,
Creams and emulsions that replenish the skin with water and oil have been used as skin care bases. Then, various moisturizers have been positively blended with various skin external preparations. However, glycerin, sorbitol, propylene glycol, maltitol, and the like, which are currently used moisturizers, tend to be sticky or have a hot sensation when mixed in a large amount. Further, amino acid-based humectants such as DL-threonine tend to have defects such as coloring and odor.
【0004】[0004]
【発明が解決すべき課題】そこで、本発明が解決すべき
課題は、真に優れた肌荒れ改善効果を有する皮膚外用剤
を提供することにある。SUMMARY OF THE INVENTION The problem to be solved by the present invention is to provide a skin external preparation having a truly excellent effect of improving rough skin.
【0005】[0005]
【課題を解決するための手段】本発明者は、上記課題の
解決に向けて鋭意検討を重ねた結果、特定のアミノエチ
ル化合物及びトラネキサム酸若しくはその塩類を含んで
なる皮膚外用剤により上記の課題を解決可能であること
を見出した。Means for Solving the Problems As a result of extensive studies aimed at solving the above-mentioned problems, the present inventor has achieved the above-mentioned problems by using a skin external preparation containing a specific aminoethyl compound and tranexamic acid or a salt thereof. It was found that can be solved.
【0006】すなわち、本発明は、下記成分(1)及び
(2)を含んでなる肌荒れ改善用皮膚外用剤(以下、本
発明皮膚外用剤ともいう)を提供する発明である。
(1)式NH2CH2CH2X (I)
(式中、Xは−SO2H又は−SO2SHである) で示さ
れるアミノエチル化合物の1種又は2種を、皮膚外用剤
全体の0.0001重量%以上、同1.0重量%以下。
(2)トラネキサム酸若しくはその塩類を、皮膚外用剤
全体の0.01重量%以上、同5.0重量%以下。That is, the present invention is an invention which provides a skin external preparation for improving rough skin (hereinafter also referred to as the skin external preparation of the present invention) comprising the following components (1) and (2). (1) One or two aminoethyl compounds represented by the formula NH 2 CH 2 CH 2 X (I) (wherein, X is —SO 2 H or —SO 2 SH), as a whole skin external preparation. 0.0001% by weight or more and 1.0% by weight or less. (2) The amount of tranexamic acid or a salt thereof is 0.01% by weight or more and 5.0% by weight or less based on the total amount of the external preparation for skin.
【0007】[0007]
【0008】[0008]
【0009】[0009]
【0010】[0010]
【0011】[0011]
【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。
A.本発明皮膚外用剤には、上記式(I)に示すアミノ
エチル化合物が配合される。式(I)に示すアミノエチ
ル化合物、すなわち、Xが−SO2H、すなわちスルフ
ィン酸基である2−アミノエチルスルフィン酸(ヒポタ
ウリン)、及びXが−SO2SH、すなわちチオスルホ
ン酸基である2−アミノエチルチオスルホン酸(チオタ
ウリン)は、共にヒトを含め多くの哺乳類の主要臓器、
例えば心臓、脳、肝臓等に含有され、また日常摂取する
食物の中にも多く含まれるものである。また、皮膚に対
する刺激、痒み、かぶれ等の副作用も報告されていな
い。よって、式(I)に示すアミノエチル化合物を本発
明皮膚外用剤に配合しても安全性については問題がない
ことは明らかである。BEST MODE FOR CARRYING OUT THE INVENTION Embodiments of the present invention will be described below. A. The external preparation for skin of the present invention contains an aminoethyl compound represented by the above formula (I). An aminoethyl compound represented by formula (I), that is, 2-aminoethylsulfinic acid (hypotaurine) in which X is —SO 2 H, that is, a sulfinic acid group, and X is —SO 2 SH, that is, a thiosulfonic acid group. -Aminoethylthiosulfonic acid (thiotaurine) is a major organ in many mammals, including humans,
For example, it is contained in the heart, brain, liver and the like, and is also contained in a large amount in foods that are ingested daily. In addition, side effects such as skin irritation, itching and rash have not been reported. Therefore, it is clear that there is no problem in safety even if the aminoethyl compound represented by the formula (I) is added to the skin external preparation of the present invention.
【0012】また、これらのアミノエチル化合物(I)
は、システイン等の入手が容易なチオ化合物から通常公
知の方法で容易に製造することが可能であり、また市販
品を本発明皮膚外用剤に配合することも可能である。こ
れらのアミノエチル化合物(I)を本発明皮膚外用剤中
に配合することにより、本発明皮膚外用剤において所望
する肌荒れ改善効果の発現に大きく寄与することができ
る。Further, these aminoethyl compounds (I)
Can be easily produced from a readily available thio compound such as cysteine by a commonly known method, and a commercially available product can be added to the external skin preparation of the present invention. By incorporating these aminoethyl compounds (I) into the external preparation for skin of the present invention, it is possible to greatly contribute to the expression of the desired skin roughening improving effect in the external preparation for skin of the present invention.
【0013】これらのアミノエチル化合物(I)の本発
明皮膚外用剤における配合量は、本発明皮膚外用剤に配
合する他の成分の種類若しくは量等によって適宜変更す
べきものであり、一概に規定されるべきものではない
が、概ね本発明皮膚外用剤全体の0.0001重量%以
上、同1.0重量%以下の範囲で配合するのが好まし
い。本発明皮膚外用剤におけるアミノエチル化合物
(I)の配合量が本発明皮膚外用剤全体の0.0001
重量%未満であると、上記の所望する肌荒れ改善効果を
本発明皮膚外用剤において発揮することが困難になり好
ましくない。また、本発明皮膚外用剤全体の1.0重量
%を越えて配合しても、配合量の増大に見合った、上記
効果の増強がもはや見られなくなり好ましくない。The blending amount of these aminoethyl compounds (I) in the external preparation for skin of the present invention should be appropriately changed according to the kind or amount of other components to be added to the external preparation for skin of the present invention, and is generally defined. Although it is not necessary, it is preferable that the amount is generally 0.0001% by weight or more and 1.0% by weight or less based on the entire skin external preparation of the present invention. The compounding amount of the aminoethyl compound (I) in the external preparation for skin of the present invention is 0.0001 of the whole external preparation for skin of the present invention.
If it is less than wt%, it is difficult to exert the desired effect of improving the above-mentioned rough skin in the external preparation for skin of the present invention, which is not preferable. Further, even if the amount exceeds 1.0% by weight of the total external preparation for skin of the present invention, the above effects corresponding to the increase in the amount added are no longer observed, which is not preferable.
【0014】そして、上記効果の発現強度と配合量との
兼ね合いから、本発明皮膚外用剤中へのアミノエチル化
合物(I)は、概ね本発明皮膚外用剤全体の0.001
重量%以上、同0.1重量%以下の範囲で配合するのが
特に好ましい。From the balance between the expression level of the above effect and the blending amount, the aminoethyl compound (I) in the external preparation for skin of the present invention is approximately 0.001% of the total amount of the external preparation for skin of the present invention.
It is particularly preferable to blend in the range of not less than 0.1 % by weight and not more than 0.1% by weight .
【0015】本発明皮膚外用剤全体の0.0001重量
%以上、同0.001重量%未満程度の配合量である
と、肌荒れ改善効果がアミノエチル化合物(I)の配合
のみでは十分ではない場合が多く、結果として、他の補
助成分等の配合量を増大させることが必要になる傾向が
ある。When the blending amount is 0.0001% by weight or more and less than 0.001% by weight based on the total weight of the external preparation for skin of the present invention, the effect of improving the rough skin is not sufficient when only the aminoethyl compound (I) is blended. However, as a result, it tends to be necessary to increase the amount of other auxiliary components and the like compounded.
【0016】また、本発明皮膚外用剤全体の0.1重量
%を越えて、かつ同1.0重量%以下程度の配合量で
は、アミノエチル化合物(I)の配合量の増大に対する
所望の効果の発現の増強が緩徐となり、むしろ他の補助
成分を積極的に配合する方が結果として優れた効果を本
発明皮膚外用剤が発揮する傾向にある。The total weight of the external preparation for skin of the present invention is 0.1%.
%, And at a compounding amount of about 1.0% by weight or less, the desired effect on the increase of the compounding amount of the aminoethyl compound (I) is slowly enhanced, but rather other auxiliary components are positively added. As a result, the external preparation for skin of the present invention tends to exert a superior effect.
【0017】前記した2種のアミノエチル化合物(I)
は、それぞれを単独に本発明皮膚外用剤中に配合するこ
とが可能であることは勿論であるが、これらを組み合わ
せて配合することも可能である。また、2種のアミノエ
チル化合物(I)を共に本発明皮膚外用剤中に配合する
場合の両者の本発明皮膚外用剤における配合比率は任意
であり、特に限定されない。The above-mentioned two aminoethyl compounds (I)
It is needless to say that each of them can be individually incorporated in the external preparation for skin of the present invention, but they can also be incorporated in combination. Further, when two kinds of aminoethyl compounds (I) are both compounded in the skin external preparation of the present invention, the compounding ratio of both of them in the skin external preparation of the present invention is arbitrary and is not particularly limited.
【0018】B.本発明皮膚外用剤には、さらにトラネ
キサム酸若しくはその塩類が配合される。これらは、抗
プラスミン剤として一般に用いられており、化粧品用途
では安全性が高い成分として一般に知られている(特公
昭47−1479号)。また、その製造法は、特許第2
40611号,特許第242664号,特許第4804
11号,特許第488168号において知られている。B. The external preparation for skin of the present invention further comprises
Xamic acid or its salts are mixed. These are generally used as antiplasmin agents and are generally known as highly safe ingredients for cosmetic use (Japanese Patent Publication No. 47-1479). In addition, the manufacturing method is the second patent.
40611, Patent 242664, Patent 4804
No. 11, Japanese Patent No. 488168.
【0019】トラネキサム酸は、融点が386〜390
℃で白色の結晶又は粉末で、無臭で、味は苦い。トラネ
キサム酸の塩類として、通常使用されるものとしては、
マグネシウム塩,カルシウム塩,カリウム塩等の金属塩
や硫酸塩等を挙げることができる。 Tranexamic acid has a melting point of 386 to 390.
White crystals or powder at ℃, odorless, and bitter in taste. Torane
As the salts of xamic acid, those commonly used include
Metal salts such as magnesium salt, calcium salt, potassium salt
And sulfates.
【0020】本発明においては、上記のトラネキサム酸
若しくはその塩類の中から1種又は2種以上が任意に選
択されて配合される。このトラネキサム酸若しくはその
塩類の本発明皮膚外用剤における配合量は、本発明皮膚
外用剤に配合する他成分の種類若しくは量等によって適
宜変更すべきものであり、一概に規定されるべきもので
はないが、概ね本発明皮膚外用剤全体の0.01重量%
以上、同5.0重量%以下の範囲で好ましく配合され、
同0.1重量%以上、同1.0重量%以下で特に好まし
く配合される。本発明皮膚外用剤におけるトラネキサム
酸若しくはその塩類の配合量が本発明皮膚外用剤全体の
0.01重量%未満であると、上記の所望する肌荒れ改
善効果を本発明皮膚外用剤において発揮することが困難
になる故に好ましくない。また、本発明皮膚外用剤全体
の5.0重量%を越えて配合しても、配合量の増大に見
合った、上記効果の増強がもはや見られず好ましくな
い。In the present invention, the above tranexamic acid is used.
Alternatively, one kind or two or more kinds are arbitrarily selected and mixed from the salts thereof. This tranexamic acid or its
The amount of salts in the external preparation for skin of the present invention should be appropriately changed according to the type or amount of other components to be added to the external preparation for skin of the present invention, and should not be specified unconditionally, but the skin of the present invention is generally used. 0.01% by weight of the total external preparation
Above, preferably blended in the range of 5.0 wt% or less ,
It is particularly preferably mixed in an amount of 0.1% by weight or more and 1.0% by weight or less . Tranexam in the external preparation for skin of the present invention
When the content of the acid or its salt is less than 0.01% by weight based on the total weight of the external preparation for skin of the present invention, it is difficult to exert the desired effect of improving rough skin on the external preparation for skin of the present invention, which is not preferable. Further, even if the amount exceeds 5.0% by weight of the total skin external preparation of the present invention, the above effect corresponding to the increase in the amount added is no longer observed, which is not preferable.
【0021】なお、上記アミノエチル化合物(I)とト
ラネキサム酸若しくはその塩類との間の配合比率は、両
成分が、上記の範囲内である限りにおいて特に限定され
るものではなく、本発明皮膚外用剤の具体的剤形に応じ
て、適宜調整することができる。ただし、上記の範囲内
においても、上記両成分のうち一方を多量に配合し、他
方を少量配合する場合には、一方の配合成分の性質のみ
が本発明皮膚外用剤において過剰に反映される傾向があ
る面は否定できない。[0021] Incidentally, the aminoethyl compound (I) bets
The mixing ratio with lanexamic acid or its salts is not particularly limited as long as both components are within the above range, and is appropriately adjusted according to the specific dosage form of the external preparation for skin of the present invention. be able to. However, even within the above range, when one of the above components is blended in a large amount and the other is blended in a small amount, only the properties of one of the blended components tend to be excessively reflected in the skin external preparation of the present invention. There is no denying that aspect.
【0022】驚くべきことに、上記アミノエチル化合物
(I)とトラネキサム酸若しくはその塩類とを共に本発
明皮膚外用剤に配合することにより、単に相加的にそれ
ぞれの配合成分が本来有する消炎効果等を発揮するのみ
ではなく、相乗的に肌荒れを防止又は改善することがで
きる。以上記載した有効成分を含有する本発明皮膚外用
剤は、その有効成分のみの配合により、肌荒れの改善と
いう所期の効果を発揮することが十分可能である。Surprisingly, when the above aminoethyl compound (I) and tranexamic acid or a salt thereof are blended together with the external preparation for skin of the present invention, the anti-inflammatory effect inherent to each blending component is merely additively added. In addition to exhibiting the above, it is possible to synergistically prevent or improve rough skin. The external preparation for skin of the present invention containing the above-mentioned active ingredient can sufficiently exhibit the intended effect of improving rough skin by blending only the active ingredient.
【0023】しかしながら、必要に応じて他の薬効成分
の配合により、皮膚外用剤が一般的に奏するであろう効
果を付与する目的で、この他の薬効成分を本発明皮膚外
用剤に配合することは、その配合により本発明の所期の
効果を損なわない範囲で可能である。However, if necessary, other medicinal ingredients are added to the skin external preparation of the present invention for the purpose of imparting an effect that the skin external preparation will generally exhibit, by adding other medicinal ingredients. Can be added within the range that does not impair the intended effect of the present invention.
【0024】例えば、保湿効果を付与することは、皮膚
の乾燥による肌荒れを防ぐ等の目的で有用である。この
場合は、例えばポリエチレングリコール、プロピレング
リコール、グルセリン、1, 3−ブチレングリコール、
ヘキシレングリコール、キシリトール、ソルビトール、
マルチトール、コンドロイチン硫酸、ヒアルロン酸、ム
コイチン硫酸、カロニン酸、アテロコラーゲン、コレス
テリル−12−ヒドロキシステアレート、乳酸ナトリウ
ム、胆汁酸塩、dl−ピロリドンカルボン酸塩、短鎖可
溶性コラーゲン、ジグリセリン(EO)PO付加物、イ
ザヨイバラ抽出物、西洋ノコギリ草抽出物、メリロート
抽出物等の保湿剤を本発明皮膚外用剤に配合することが
可能である。For example, imparting a moisturizing effect is useful for the purpose of preventing rough skin due to dry skin. In this case, for example, polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol,
Hexylene glycol, xylitol, sorbitol,
Maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salt, dl-pyrrolidone carboxylate, short chain soluble collagen, diglycerin (EO) PO It is possible to add a moisturizer such as an adduct, an extract of Ibiza rose, an extract of sawtooth grass and an extract of meliloth to the external preparation for skin of the present invention.
【0025】抗紫外線効果を付与することは、皮膚にお
ける過度の紫外線被曝による肌の損傷を抑制する上で有
用である。この場合は、例えばメチルアントラニレー
ト、ホモメンチル−N−アセチルアントラニレート等の
アントラニル酸系紫外線吸収剤;2, 4−ジヒドロキシ
ベンゾフェノン、2, 2' −ジヒドロキシ−4−メトキ
シベンゾフェノン、2, 2' −ジヒドロキシ−4, 4'
−ジメトキシベンゾフェノン、2, 2',4, 4' −テト
ラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メ
トキシベンゾフェノン、2−ヒドロキシ−4−メトキシ
−4' −メチルベンゾフェノン、2−ヒドロキシ−4−
メトキシベンゾフェノン−5−スルホン酸塩、4−フェ
ニルベンゾフェノン、2−エチルヘキシル−4' −フェ
ニル−ベンゾフェノン−2−カルボキシレート、2−ヒ
ドロキシ−4−n−オクトキシベンゾフェノン、4−ヒ
ドロキシ−3−カルボキシベンゾフェノン等のベンゾフ
ェノン系紫外線吸収剤;2, 2’−ヒドロキシ−5−メ
チルフェニルベンゾトリアゾール、2−( 2' −ヒドロ
キシ−5’−t−オクチルフェニル) ベンゾトリアゾー
ル、2−( 2' −ヒドロキシ−5’−メチルフェニル)
ベンゾトリアゾール等のベンゾトリアゾール系紫外線吸
収剤;ジアニソイルメタン、4−メトキシ−4' −t−
ブチルジベンゾイルメタン(パルソールA)等の長波長
紫外線吸収剤を本発明皮膚外用剤に配合することが可能
である。Providing an anti-ultraviolet effect is useful for suppressing damage to the skin due to excessive exposure of the skin to ultraviolet rays. In this case, for example methyl anthranilate, homomenthyl -N- acetyl anthranilate anthranilic acid UV absorbers such as anthranilate; 2, 4-dihydroxybenzophenone, 2, 2 '- dihydroxy-4-methoxybenzophenone, 2, 2' -Dihydroxy-4,4 '
-Dimethoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-
Methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone benzophenone ultraviolet absorbers and the like; 2, 2'-hydroxy-5-methylphenyl benzotriazole, 2- (2 '- hydroxy-5'-t-octylphenyl) benzotriazole, 2- (2' - hydroxy-5 '-Methylphenyl)
Benzotriazole ultraviolet absorbers such as benzotriazole; Ziani soil methane, 4-methoxy -4 '-t-
A long-wavelength ultraviolet absorber such as butyldibenzoylmethane (parsol A) can be added to the skin external preparation of the present invention.
【0026】また、パラアミノ安息香酸 (以下、PAB
Aという) 、PABAモノグリセリンエステル、N,N
−ジプロポキシPABAエチルエステル、N,N−ジエ
トキシPABAエチルエステル、N,N−ジメチルPA
BAエチルエステル、N,N−ジメチルPABAブチル
エステル、N,N−ジメチルPABAアミルエステル等
の安息香酸系紫外線吸収剤;ジプロピレングリコールサ
リシレート、エチレングリコールサリシレート、ミリス
チルサリシレート、メチルサリシレート、アミルサリシ
レート、メンチルサリシレート、ホモメンチルサリシレ
ート、オクチルサリシレート、フェニルサリシレート、
ベンジルサリシレート、p−イソプロパノールフェニル
サリシレート等のサリチル酸系紫外線吸収剤;オクチル
シンナメート、エチル−4−イソプロピルシンナメー
ト、メチル−2, 5−ジイソプロピルシンナメート、エ
チル−2, 4−ジイソプロピルシンナメート、メチル−
2,4−ジイソプロピルシンナメート、プロピル−p−
メトキシシンナメート、イソプロピル−p−メトキシシ
ンナメート、イソアミル−p−メトキシシンナメート、
オクチル−p−メトキシシンナメート( 2−エチルヘキ
シル−p−メトキシシンナメート) 、2−エトキシエチ
ル−p−メトキシシンナメート、シクロヘキシル−p−
メトキシシンナメート、エチル−α−シアノ−β−フェ
ニルシンナメート、2−エチルヘキシル−α−シアノ−
β−フェニルシンナメート、グリセリルモノ−2−エチ
ルヘキサノイル−ジパラメトキシシンナメート、メトキ
シケイ皮酸オクチル、3, 4, 5−トリメトキシケイ皮
酸−3−メチル−4−[メチルビス(トリメチルシロキ
シ)シリル]ブチル、p−ジメトキシケイ皮酸モノエチ
ルエステル等のケイ皮酸系紫外線吸収剤;3−( 4’−
メチルベンジリデン) −d, 1−カンファー、3−ベン
ジリデン−d,1−カンファー、5−( 3, 3−ジメチ
ル−2−ノルボルニリデン) −3−ペンテン−2−オン
等のカンファー誘導体;ウロカニン酸、ウロカニン酸エ
チルエステル、2−フェニル−5−メチルベンゾオキサ
ゾール、ジベンザラジン等の中波長紫外線(UVB)吸
収剤を本発明皮膚外用剤に配合することが可能である。Further, para-aminobenzoic acid (hereinafter referred to as PAB
A), PABA monoglycerin ester, N, N
-Dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl PA
Benzoic acid type ultraviolet absorbers such as BA ethyl ester, N, N-dimethyl PABA butyl ester, N, N-dimethyl PABA amyl ester; dipropylene glycol salicylate, ethylene glycol salicylate, myristyl salicylate, methyl salicylate, amyl salicylate, menthyl salicylate. , Homomenthyl salicylate, octyl salicylate, phenyl salicylate,
Salicylic acid-based UV absorbers such as benzyl salicylate and p-isopropanol phenyl salicylate; octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-
2,4-diisopropyl cinnamate, propyl-p-
Methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate,
Octyl-p-methoxycinnamate (2-ethylhexyl-p-methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-
Methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-
β-phenylcinnamate, glyceryl mono-2-ethylhexanoyl-diparamethoxycinnamate, octyl methoxycinnamate, 3,4,5-trimethoxycinnamate-3-methyl-4- [methylbis (trimethylsiloxy) ) Silyl] butyl, cinnamic acid-based UV absorbers such as p-dimethoxycinnamic acid monoethyl ester; 3- (4'-
Camphor derivatives such as methylbenzylidene) -d, 1-camphor, 3-benzylidene-d, 1-camphor, 5- (3,3-dimethyl-2-norbornylidene) -3-penten-2-one; urocanic acid, urocanine Medium wavelength ultraviolet (UVB) absorbers such as acid ethyl ester, 2-phenyl-5-methylbenzoxazole and dibenzalazine can be added to the external skin preparation of the present invention.
【0027】さらに、酸化チタン(TiO2 )、タルク
(MgSiO2 )、カルミン(FeO2 )、ベントナイ
ト、カオリン、酸化亜鉛(ZnO)等の紫外線遮断剤を
本発明皮膚外用剤に配合することが可能である。Further, an ultraviolet blocking agent such as titanium oxide (TiO 2 ), talc (MgSiO 2 ), carmine (FeO 2 ), bentonite, kaolin, zinc oxide (ZnO) can be added to the external skin preparation of the present invention. Is.
【0028】本発明皮膚外用剤に美白効果を付与するこ
とも有益である。この場合は、胎盤抽出物、グルタチオ
ン、ユキノシタ抽出物等の美白剤を本発明皮膚外用剤に
配合することが可能である。It is also beneficial to impart a whitening effect to the external preparation for skin of the present invention. In this case, a whitening agent such as a placenta extract, glutathione, and Yukinoshita extract can be added to the external skin preparation of the present invention.
【0029】消炎効果を付与することも、皮膚の炎症を
抑えて肌荒れを防止する上で有用である。この場合は、
グリチルリチン酸誘導体、グリチルレチン酸誘導体、サ
リチル酸誘導体、ヒノキチオール、酸化亜鉛、アラント
イン等の消炎剤を本発明皮膚外用剤に配合することが可
能である。Adding an anti-inflammatory effect is also useful for suppressing skin inflammation and preventing rough skin. in this case,
An anti-inflammatory agent such as a glycyrrhizinic acid derivative, a glycyrrhetinic acid derivative, a salicylic acid derivative, hinokitiol, zinc oxide, and allantoin can be added to the external skin preparation of the present invention.
【0030】同様に紫外線による皮膚の損傷を緩和する
等の目的で、ローヤルゼリー、感光素、コレステロール
誘導体、幼牛血液抽出物等の賦活剤;ノニル酸ワレニル
アミド、ニコチン酸ベンジルエステル、ニコチン酸β−
ブトキシエチルエステル、カプサイシン、ジンゲロン、
カンタリスチンキ、イクタモール、カフェイン、タンニ
ン酸、α−ボルネオール、ニコチン酸トコフェロール、
イノシトールヘキサニコチネート、シクランデレート、
シンナリジン、トラゾリン、アセチルコリン、ベラパミ
ル、セファランチン、γ−オリザノール等の血行促進
剤;硫黄、チアントール等の抗脂漏剤等を本発明皮膚外
用剤中に配合することができる。Similarly, for the purpose of alleviating skin damage caused by ultraviolet rays, activating agents such as royal jelly, photosensitizer, cholesterol derivative, and calf blood extract; nonylvalerenamide, nicotinic acid benzyl ester, nicotinic acid β-
Butoxyethyl ester, capsaicin, zingerone,
Cantharis tincture, ictamol, caffeine, tannic acid, α-borneol, tocopherol nicotinate,
Inositol hexanicotinate, cyclanderate,
Blood circulation promoters such as cinnarizine, trazoline, acetylcholine, verapamil, cepharanthin, γ-oryzanol, etc .; antiseborrheic agents such as sulfur, thiantol, etc. can be added to the external preparation for skin of the present invention.
【0031】また、多様な目的から、オウバク抽出成
分、オウレン抽出成分、シコン抽出成分、シャクヤク抽
出成分、センブリ抽出成分、バーチ抽出成分、セージ抽
出成分、ビワ抽出成分、ニンジン抽出成分、アロエ抽出
成分、ゼニアオイ抽出成分、アイリス抽出成分、ブドウ
抽出成分、ヨクイニン抽出成分、ヘチマ抽出成分、ユリ
抽出成分、サフラン抽出成分、センキュウ抽出成分、シ
ョウキュウ抽出成分、オトギリソウ抽出成分、オノニス
抽出成分、ローズマリー抽出成分、ニンニク抽出成分、
トウガラシ抽出成分、イザヨイバラ抽出成分、西洋ノコ
ギリ草抽出成分、メリロート抽出成分、チンピ、トウキ
等の植物抽出物を本発明皮膚外用剤中に配合することも
可能である。In addition, for various purposes, oyster extract component, laurel extract component, shikon extract component, peony extract component, assembly extract component, birch extract component, sage extract component, loquat extract component, carrot extract component, aloe extract component, Mallow extract component, iris extract component, grape extract component, Yokuinin extract component, loofah extract component, lily extract component, saffron extract component, senkyu extract component, ginger extract component, Hypericum extract component, Ononis extract component, rosemary extract component, Garlic extract ingredient,
It is also possible to mix a pepper extract component, an Iza oyster rose extract component, a western saw grass extract component, a merlot extract component, a botanical extract such as chimpi, and Japanese clover in the skin external preparation of the present invention.
【0032】さらに、各々のビタミンが有する固有の効
果、例えば皮膚の賦活効果を本発明皮膚外用剤にさらに
付与するために、ビタミンA油、レチノール、酢酸レチ
ノール等のビタミンA類;リボフラビン、酪酸リボフラ
ビン、フラビンアデニンヌクレオチド等のビタミンB2
類;ピリドキシン塩酸塩、ピリドキシンジオクタノエー
ト等のビタミンB6 類;L−アスコルビン酸、L−アス
コルビン酸ジパルミチン酸エステル、L−アスコルビン
酸−2−硫酸ナトリウム、L−アスコルビン酸リン酸エ
ステル、DL−α−トコフェロール−L−アスコルビン
酸リン酸ジエステルジカリウム等のビタミンC類;パン
トテン酸カルシウム、D−パントテニルアルコール、パ
ントテニルエチルエーテル、アセチルパントテニルエチ
ルエーテル等のパントテン酸類;エルゴカルシフェロー
ル、コレカルシフェロール等のビタミンD類;ニコチン
酸、ニコチン酸アミド、ニコチン酸ベンジル等のニコチ
ン酸類;α−トコフェロール、酢酸トコフェロール、ニ
コチン酸DL−α−トコフェロール、コハク酸DL−α
−トコフェロール等のビタミンE類;ビタミンP、ビオ
チン等のその他のビタミン類を本発明皮膚外用剤中に配
合することができる。Further, in order to further impart a unique effect of each vitamin, such as a skin activating effect, to the external preparation for skin of the present invention, vitamin A oils such as vitamin A oil, retinol and retinol acetate; riboflavin, riboflavin butyrate. , Flavin adenine nucleotides and other vitamin B 2
S; pyridoxine hydrochloride, vitamin B 6 such as pyridoxine dioctanoate; L-ascorbic acid, L- ascorbic acid dipalmitate ester, L- ascorbic acid-2-sodium sulfate, L- ascorbic acid phosphoric acid ester, Vitamin Cs such as DL-α-tocopherol-L-ascorbic acid phosphoric acid diester dipotassium; pantothenic acids such as calcium pantothenate, D-pantothenyl alcohol, pantothenyl ethyl ether, acetylpantothenyl ethyl ether; ergocalciferol, cole Vitamin Ds such as calciferol; Nicotinic acid, nicotinic acid amide, nicotinic acid such as benzyl nicotinate; α-tocopherol, tocopherol acetate, DL-α-tocopherol nicotinate, DL-α succinate
-Vitamin Es such as tocopherol; other vitamins such as vitamin P and biotin can be incorporated into the external preparation for skin of the present invention.
【0033】なお、上に挙げた薬効成分に、本発明皮膚
外用剤に配合可能な他の薬効成分が限定されるものでは
ない。また、上に挙げた他の薬効成分に対応する薬効
も、上記に限定されるものではない。例えば、ビタミン
C類は美白成分として用いることができると共に、酸化
防止助剤としても用いることが可能である。さらに、上
に挙げた他の薬効成分は、単独で本発明皮膚外用剤に配
合することの他に、2種以上の上記薬効成分を、目的に
応じ、適宜組み合わせて配合することも可能である。The above-mentioned medicinal components are not limited to other medicinal components which can be incorporated into the external preparation for skin of the present invention. The medicinal effects corresponding to the other medicinal components listed above are not limited to the above. For example, vitamin Cs can be used as a whitening component and also as an antioxidant aid. Further, the other medicinal ingredients listed above may be blended alone in the external preparation for skin of the present invention, or two or more medicinal ingredients may be blended in an appropriate combination according to the purpose. .
【0034】本発明は、外皮に適用される化粧料、医薬
品、医薬部外品等に広く適用することが可能であり、そ
の剤形も水溶液系、可溶化系、乳化系、粉末系、油液
系、ゲル系、軟膏系、エアゾール系、水−油2層系、水
−油−粉末3層系等、幅広い剤形を採り得る。すなわ
ち、基礎化粧品であれば、洗顔料,化粧水,乳液,クリ
ーム,ジェル,エッセンス(美容液),パック・マスク
等の形態や、さらにヘアトニック,ヘアークリーム,シ
ャンプー,ヘアリンス等の頭髪化粧品の形態に、上記の
多様な剤形において広く適用可能である。また、メーキ
ャップ化粧品であれば、ファンデーション等の形態に広
く適用可能である。さらに、医薬品又は医薬部外品であ
れば、各種の軟膏剤等の形態に広く適用が可能である。
そして、これらの剤形及び形態に、本発明皮膚外用剤の
採り得る形態が限定されるものではない。INDUSTRIAL APPLICABILITY The present invention can be widely applied to cosmetics, pharmaceuticals, quasi-drugs and the like applied to the outer skin, and its dosage form is also an aqueous solution type, a solubilizing type, an emulsifying type, a powder type, an oil type. A wide variety of dosage forms such as liquid type, gel type, ointment type, aerosol type, water-oil two-layer type, water-oil-powder three-layer type can be adopted. In other words, in the case of basic cosmetics, the form of facial cleansers, lotions, milky lotions, creams, gels, essences (cosmetics), packs and masks, and hair cosmetics such as hair tonics, hair creams, shampoos and hair rinses In addition, it is widely applicable in the above various dosage forms. Further, makeup cosmetics can be widely applied to forms such as foundations. Furthermore, as long as it is a drug or a quasi drug, it can be widely applied in the form of various ointments and the like.
The forms that the external preparation for skin of the present invention can take are not limited to these forms and forms.
【0035】本発明皮膚外用剤においては、上記の所望
する剤形及び形態に応じて通常公知の基剤成分を、その
配合により本発明の所期の効果が損なわれない範囲で広
く配合することができる。In the external preparation for skin of the present invention, generally known base components are blended widely according to the above-mentioned desired dosage form and form within the range in which the intended effect of the present invention is not impaired by the blending thereof. You can
【0036】すなわち、アボガド油、ツバキ油、月見草
油、タートル油、マカデミアナッツ油、トウモロコシ
油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ
油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ
油、アマニ油、サフラワー油、綿実油、エノ油、大豆
油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ
油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、
トリオクタン酸グリセリン、トリイソパルミチン酸グリ
セリン等の液体油脂;カカオ脂、ヤシ油、馬脂、硬化ヤ
シ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、
豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロ
ウ、硬化ヒマシ油等の固体油脂;ミツロウ、カンデリラ
ロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボ
タロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、
カポックロウ、酢酸ラノリン、液状ラノリン、サトウキ
ビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキ
シル、還元ラノリン、ジョジョバロウ、硬質ラノリン、
セラックロウ、POEラノリンアルコールエーテル、P
OEラノリンアルコールアセテート、POEコレステロ
ールエーテル、ラノリン脂肪酸ポリエチレングリコー
ル、POE水素添加ラノリンアルコールエーテル等のロ
ウ類;流動パラフィン、オゾケライト、スクワレン、プ
リスタン、パラフィン、セレシン、スクワレン、ワセリ
ン、マイクロクリスタリンワックス等の油分等の炭化水
素油;ラウリン酸、ミリスチン酸、パルミチン酸、ステ
アリン酸、ベヘン(ベヘニン)酸、オレイン酸、12−
ヒドロキシステアリン酸、ウンデシレン酸、トール酸、
イソステアリン酸、リノール酸、リノレイン酸、エイコ
サペンタエン酸(EPA)、ドコサヘキサエン酸(DH
A)等の高級脂肪酸;ラウリルアルコール、セチルアル
コール、ステアリルアルコール、ベヘニルアルコール、
ミリスチルアルコール、オレイルアルコール、セトステ
アリルアルコール等の直鎖アルコール、モノステアリル
グリセリンエーテル(バチルアルコール)、2−デシル
テトラデシノール、ラノリンアルコール、コレステロー
ル、フィトステロール、ヘキシルドデカノール、イソス
テアリルアルコール、オクチルドデカノール等の分枝鎖
アルコール等の高級アルコール;ミリスチン酸イソプロ
ピル、オクタン酸セチル、ミリスチン酸オクチルドデシ
ル、パルミチン酸イソプロピル、ステアリン酸ブチル、
ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイ
ン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸
セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸
イソセチル、イソステアリン酸イソセチル、12−ヒド
ロキシステアリル酸コレステリル、ジ−2−エチルヘキ
シル酸エチレングリコール、ジペンタエリスリトール脂
肪酸エステル、モノイソステアリン酸N−アルキルグリ
コール、ジカプリン酸ネオペンチルグリコール、リンゴ
酸ジイソステアリル、ジ−2−ヘプチルウンデカン酸グ
リセリン、トリ−2−エチルヘキシル酸トリメチロール
プロパン、トリイソステアリン酸トリメチロールプロパ
ン、テトラ−2−エチルヘキシル酸ペンタンエリスリト
ール、トリー2−エチルヘキシル酸グリセリン、トリイ
ソステアリン酸トリメチロールプロパン、セチル−2−
エチルヘキサノエート、2−エチルヘキシルパルミテー
ト、トリミリスチン酸グリセリン、トリ−2−ヘプチル
ウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエス
テル、オレイン酸オイル、セトステアリルアルコール、
アセトグリセライド、パルミチン酸2−ヘプチルウンデ
シル、アジピン酸ジイソブチル、N−ラウロイル−L−
グルタミン酸−2−オクチルドデシルエステル、アジピ
ン酸ジ−2−ヘプチルウンデシル、エチルラウレート、
セバチン酸ジ−2−エチルヘキシル、ミリスチン酸2−
ヘキシルデシル、パルミチン酸2−ヘキシルデシル、ア
ジピン酸2−ヘキシルデシル、セバチン酸ジイソプロピ
ル、コハク酸2−エチルヘキシル、酢酸エチル、酢酸ブ
チル、酢酸アミル、クエン酸トリエチル等の合成エステ
ル油;ジメチルポリシロキサン、メチルフェニルポリシ
ロキサン,メチルハイドロジェンポリシロキサン等の鎖
状ポリシロキサン、デカメチルポリシロキサン,ドデカ
メチルポリシロキサン,テトラメチルテトラハイドロジ
ェンポリシロキサンなどの環状ポリシロキサン、3次元
網目構造を形成しているシリコン樹脂、シリコンゴム等
のシリコン類;セッケン用素地、ラウリン酸ナトリウ
ム、パルミチン酸ナトリウム等の脂肪酸セッケン、ラウ
リル硫酸ナトリウム、ラウリル硫酸K等の高級アルキル
硫酸エステル塩、POEラウリル硫酸トリエタノールア
ミン、POEラウリル硫酸ナトリウム等のアルキルエー
テル硫酸エステル塩、ラウロイルサルコシンナトリウム
等のN−アシルサルコシン酸、N−ミリストイル−N−
メチルタウリンナトリウム、ヤシ油脂肪酸メチルタウリ
ッドナトリウム、ラウリルメチルタウリッドナトリウム
等の高級脂肪酸アミドスルホン酸塩、POEオレイルエ
ーテルリン酸ナトリウム、POEステアリルエーテルリ
ン酸等のリン酸エステル塩、ジ−2−エチルヘキシルス
ルホコハク酸ナトリウム、モノラウロイルモノエタノー
ルアミドポリオキシエチレンスルホコハク酸ナトリウ
ム、ラウリルポリプロピレングリコールスルホコハク酸
ナトリウム等のスルホコハク酸塩、リニアドデシルベン
ゼンスルホン酸ナトリウム、リニアドデシルベンゼンス
ルホン酸トリエタノールアミン、リニアドデシルベンゼ
ンスルホン酸等のアルキルベンゼンスルホン酸塩、N−
ラウロイルグルタミン酸モノナトリウム、N−ステアロ
イルグルタミン酸ジナトリウム、N−ミリストイル−L
−グルタミン酸モノナトリウム等のN−アシルグルタミ
ン酸塩、硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等
の高級脂肪酸エステル硫酸エステル塩、ロート油等の硫
酸化油、POEアルキルエーテルカルボン酸、POEア
ルキルアリルエーテルカルボン酸塩、α−オレフィンス
ルホン酸塩、高級脂肪酸エステルスルホン酸塩、二級ア
ルコール硫酸エステル塩、高級脂肪酸アルキロールアミ
ド硫酸エステル塩、ラウロイルモノエタノールアミドコ
ハク酸ナトリウム、N−パルミトイルアスパラギン酸ジ
トリエタノールアミン、カゼインナトリウム等のアニオ
ン系界面活性剤;塩化ステアリルトリメチルアンモニウ
ム、塩化ラウリルトリメチルアンモニウム等のアルキル
トリメチルアンモニウム塩、塩化ジステアリルジメチル
アンモニウムジアルキルジルキルジメチルアンモニウム
塩、塩化ポリ( N,N' −ジメチル−3, 5−メチレン
ピペリジニウム)、塩化セチルピリジニム等のアルキル
ピリジニウム塩、アルキル四級アンモニウム塩、アルキ
ルジメチルベンジルアンモニウム塩、アルキルイソキノ
リニウム塩、ジアルキルモリホニウム塩、POEアルキ
ルアミン、アルキルアミン塩、ポリアミン脂肪酸誘導
体、アミルアルコール脂肪酸誘導体、塩化ベンザルコニ
ウム、塩化ベンゼトニウム等のカチオン系界面活性剤;
2−ウンデシル−N,N, N−( ヒドロキシエチルカル
ボキシメチル) −2−イミダゾリンナトリウム、2−コ
コイル−2−イミタゾリニウムヒドロキサイド−1−カ
ルボキシエチロキシ2ナトリウム塩等の、イミダゾリン
系両性界面活性剤、2−ヘプタデシル−N−カルボキシ
メチル−N−ヒドロキシエチルイミダゾリニウムベタイ
ン、ラウリルジメチルアミノ酢酸ベタイン、アルキルベ
タイン、アミドベタイン、スルホベタイン等のベタイン
系界面活性剤等の両性界面活性剤;ソルビタンモノオレ
エート、ソルビタンモノイソステアレート、ソルビタン
モノラウレート、ソルビタンモノパルミテート、ソルビ
タンモノステアレート、ソルビタンセスキオレエート、
ソルビタントリオレエート、ペンタ−2−エチルヘキシ
ル酸ジグリセロールソルビタン、テトラ−2−エチルヘ
キシル酸ジグリセロールソルビタン等のソルビタン脂肪
酸エステル類、モノ綿実油脂肪酸グリセリン、モノエル
カ酸グリセリン、セスキオレイン酸グリセリン、モノス
テアリン酸グリセリン、α, α' −オレイン酸ピログル
タミン酸グリセリン、モノステアリン酸グリセリンリン
ゴ酸等のグリセリンポリグリセリン脂肪酸類、モノステ
アリン酸プロピレングリコール等のプロピレングリコー
ル脂肪酸エステル類、硬化ヒマシ油誘導体、グリセリン
アルキルエーテル、ポリオキシエチレン・メチルポリシ
ロキサン共重合体等の親油性非イオン界面活性剤;PO
Eソルビタンモノオレエート、POE−ソルビタンモノ
ステアレート、POE−ソルビタンモノオレート、PO
E−ソルビタンテトラオレエート等のPOEソルビタン
脂肪酸エステル類、POE−ソルビットモノラウレー
ト、POE−ソルビットモノオレエート、POE−ソル
ビットペンタオレエート、POE−ソルビットモノステ
アレート等のPOEソルビット脂肪酸エステル類、PO
E−グリセリンモノステアレート、POE−グリセリン
モノイソステアレート、POE−グリセリントリイソス
テアレート等のPOEグリセリン脂肪酸エステル類、P
OEモノオレエート、POEジステアレート、POEモ
ノジオレエート、システアリン酸エチレングリコール等
のPOE脂肪酸エステル類、POEラウリルエーテル、
POEオレイルエーテル、POEステアリルエーテル、
POEベヘニルエーテル、POE2−オクチルドデシル
エーテル、POEコレスタノールエーテル等のPOEア
ルキルエーテル類、POEオクチルフェニルエーテル、
POEノニルフェニルエーテル、POEジノニルフェニ
ルエーテル等のPOEアルキルフェニルエーテル類、ブ
ルロニック等のプルアロニック型類、POE・POPセ
チルエーテル、POE・POP2−デシルテトラデシル
エーテル、POE・POPモノブチルエーテル、POE
・POP水添ラノリン、POE・POPグリセリンエー
テル等のPOE・POPアルキルエーテル類、テトロニ
ック等のテトラPOE・テトラPOPエチレンジアミン
縮合物類、POEヒマシ油、POE硬化ヒマシ油、PO
E硬化ヒマシ油モノイソステアレート、POE硬化ヒマ
シ油トリイソステアレート、POE硬化ヒマシ油モノピ
ログルタミン酸モノイソステアリン酸ジエステル、PO
E硬化ヒマシ油マレイン酸等のPOEヒマシ油硬化ヒマ
シ油誘導体、POEソルビットミツロウ等のPOEミツ
ロウ・ラノリン誘導体、ヤシ油脂肪酸ジエタノールアミ
ド、ラウリン酸モノエタノールアミド、脂肪酸イソプロ
パノールアミド等のアルカノールアミド、POEプロピ
レングリコール脂肪酸エステル、POEアルキルアミ
ン、POE脂肪酸アミド、ショ糖脂肪酸エステル、PO
Eノニルフェニルホルムアルデヒド縮合物、アルキルエ
トキシジメチルアミンオキシド、トリオレイルリン酸等
の親水性非イオン界面活性剤;エチルパラベン、ブチル
パラベン等の防腐剤;アラアビアガム,トラガカントガ
ム,ガラクタン,グアガム,キャロブガム,カラヤガ
ム,カラギーナン,ペクチン,カンテン,クインスシー
ド(マルメロ),アルゲコロイド(カッソウエキス),
デンプン(コメ,トウモロコシ,バレイショ,コム
ギ),グリチルリチン酸等の植物系高分子、キサンタン
ガム,デキストラン,サクシノグルカン,ブルラン等の
微生物系高分子、コラーゲン,カゼイン,アルブミン,
ゼラチン等の動物系高分子等の天然の水溶性高分子;カ
ルボキシメチルデンプン、メチルヒドロキシプロピルデ
ンプン等のデンプン系高分子メチルセルロース、ニトロ
セルロース、エチルセルロース、メチルヒドロキシプロ
ピルセルロース、ヒドロキシエチルセルロース、セルロ
ース硫酸ナトリウム、ヒドロキシプロピルセルロース、
カルボキシメチルセルロースナトリウム(CMC)、結
晶セルロース、セルロース末等のセルロース系高分子、
アルギン酸ナトリウム、アルギン酸プロピレングリコー
ルエステル等のアルギン酸系高分子等の半合成の水溶性
高分子;ポリビニルアルコール、ポリビニルメチルエー
テル、ポリビニルピロリドン、カルボキシビニルポリマ
ー( カーボポール) 、アルキル変性カルボキシビニルポ
リマー等のビニル系高分子、ポリエチレングリコール2
000、4000、6000等のポリオキシエチレン系
高分子、ポリオキシエチレンポリオキシプロピレン共重
合体共重合系高分子、ポリアクリル酸ナトリウム、ポリ
エチルアクリレート、ポリアクリルアミド等のアクリル
系高分子、ポリエチレンイミン、カチオンポリマー等の
合成の水溶性高分子;ベントナイト、ケイ酸A1Mg
(ビーガム) 、ラポナイト、ヘクトライト、無水ケイ酸
等の無機の水溶性高分子;アラビアガム、カラギーナ
ン、カラヤガム、トラガカントガム、キャロブガム、ク
インスシード(マルメロ)、カゼイン、デキストリン、
ゼラチン、ペクチン酸ナトリウム、アラギン酸ナトリウ
ム、メチルセルロース、エチルセルロース、CMC、ヒ
ドロキシエチルセルロース、ヒドロキシプロピルセルロ
ース、PVA、PVM、PVP、ポリアクリル酸ナトリ
ウム、カルボキシビニルポリマー、ローカストビーンガ
ム、グアーガム、タマリントガム、ジアルキルジメチル
アンモニウム硫酸セルロース、キサンタンガム、ケイ酸
アルミニウムマグネシウム、ベントナイト、ヘクトライ
ト等の増粘剤;タルク、カリオン、雲母、絹雲母(セリ
サイト)、白雲母、金雲母、合成雲母、紅雲母、黒雲
母、リチア雲母、パーミキュライト、炭酸マグネシウ
ム、炭酸カルシウム、ケイ酸アルミニウム、ケイ酸バリ
ウム、ケイ酸カルシウム、ケイ酸マグネシウム、ケイ酸
ストロンチウム、タングステン酸金属塩、マグネシウ
ム、シリカ、ゼオライト、硫酸バリウム、焼成硫酸カル
シウム(焼セッコウ)、リン酸カルシウム、弗素アパタ
イト、ヒドロキシアパタイト、セラミックパウダー、金
属石鹸(ミリスチン酸亜鉛、パルミチン酸カルシウム、
ステアリン酸アルミニウム)、窒化ホウ素等の無機粉
末、ポリアミド樹脂粉末(ナイロン粉末)、ポリエチレ
ン粉末、ポリメタクリル酸メチル粉末、ポリスチレン粉
末、スチレンとアクリル酸の共重合体樹脂粉末、ベンゾ
グアナミン樹脂粉末、ポリ四弗化エチレン粉末、セルロ
ース粉末等の有機粉末等の粉末成分;二酸化チタン,酸
化亜鉛等の無機白色顔料、酸化鉄(ベンガラ),チタン
酸鉄等の無機赤色系顔料,γ−酸化鉄等の無機褐色系顔
料、黄酸化鉄,黄土等の無機黄色系顔料黒酸化鉄、カー
ボンブラック,低次酸化チタン等の無機黒色系顔料、マ
ンゴバイオレット,コバルトバイオレット等の無機紫色
系顔料、酸化クロム,水酸化クロム,チタン酸コバルト
等の無機緑色系顔料、群青,紺青等の無機青色系顔料、
酸化チタンコーテッドマイカ,酸化チタンコーテッドオ
キシ塩化ビスマス,酸化チタンコーテッドタルク,着色
酸化チタンコーテッドマイカ,オキシ塩化ビスマス,魚
鱗箔等のパール顔料,アルミニウムパウダー,カッパー
パウダー等の金属粉末顔料、赤色201号,赤色202
号,赤色204号,赤色205号,赤色220号,赤色
226号,赤色228号,赤色405号,橙色203
号,橙色204号,黄色205号,黄色401号及び青
色404号などの有機顔料、赤色3号,赤色104号,
赤色106号,赤色227号,赤色230号,赤色40
1号,赤色505号,橙色205号,黄色4号,黄色5
号,黄色202号,黄色203号,緑色3号,青色1号
などのジルコニウム、バリウム又はアルミニウムレーキ
等の有機顔料、クロロフィル,β−カロリン等の天然色
素等、チタンイエロー、カーサミン、紅花赤等の色剤
等;さらに香料、水、アルコール等を必要に応じて本発
明皮膚外用剤中に適宜配合することができる。本発明皮
膚外用剤の具体的な処方については、後述する実施例に
おいて記載する。That is, avocado oil, camellia oil, evening primrose oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern oil, castor oil, linseed oil. Oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, cinnamon oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin,
Liquid fats and oils such as glycerin trioctanoate and glycerin triisopalmitate; cocoa butter, coconut oil, horse fat, hardened coconut oil, palm oil, beef tallow, sheep fat, hardened beef tallow, palm kernel oil,
Solid fats and oils such as pork fat, beef bone fat, mokuro kernel oil, hydrogenated oil, beef leg oil, mokuro, hydrogenated castor oil; beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ivotaro, whale wax, montan wax, nukarou, lanolin,
Kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, jojoba wax, hard lanolin,
Shellac wax, POE lanolin alcohol ether, P
Waxes such as OE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether; oils such as liquid paraffin, ozokerite, squalene, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, etc. Hydrocarbon oils; lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, 12-
Hydroxystearic acid, undecylenic acid, tallic acid,
Isostearic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DH
Higher fatty acids such as A); lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol,
Linear alcohols such as myristyl alcohol, oleyl alcohol, and cetostearyl alcohol, monostearyl glycerin ether (batyl alcohol), 2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterols, hexyldecanol, isostearyl alcohol, octyldodecanol, etc. Branched alcohols such as isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate,
Hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearylate, ethylene glycol di-2-ethylhexylate. , Dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, tri-2-ethylhexyl trimethylolpropane, triisostearate tri Methylol propane, tetra-2-ethylhexyl pentane erythritol, tri-2-ethylhexyl glycerin, triisostearate Trimethylol propane, cetyl-2
Ethyl hexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, glyceride tri-2-heptylundecanoate, castor oil fatty acid methyl ester, oleic acid oil, cetostearyl alcohol,
Acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-
Glutamic acid-2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate,
Di-2-ethylhexyl sebacate, myristic acid 2-
Hexyldecyl, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, synthetic ester oils such as ethyl acetate, butyl acetate, amyl acetate, triethyl citrate; dimethylpolysiloxane, methyl Chain polysiloxanes such as phenylpolysiloxane and methylhydrogenpolysiloxane, cyclic polysiloxanes such as decamethylpolysiloxane, dodecamethylpolysiloxane, and tetramethyltetrahydrogenpolysiloxane, and silicone resins that form a three-dimensional network structure. , Silicones such as silicone rubber; base for soap, fatty acid soap such as sodium laurate, sodium palmitate, etc., higher alkyl sulfate ester salt such as sodium lauryl sulfate, K lauryl sulfate, P E triethanolamine lauryl sulfate, alkyl ether sulfate salts such as POE sodium lauryl sulfate, sodium lauroyl sarcosinate, etc. N- acyl sarcosinates, N- myristoyl -N-
Methyl taurine sodium, coconut oil fatty acid methyl tauride sodium, lauryl methyl tauride sodium and other higher fatty acid amide sulfonates, POE oleyl ether phosphate sodium, POE stearyl ether phosphate and other phosphate ester salts, di-2-ethylhexyl Sodium sulfosuccinate, monolauroyl monoethanolamide polyoxyethylene sodium sulfosuccinate, sulfosuccinates such as sodium lauryl polypropylene glycol sulfosuccinate, sodium linear dodecylbenzenesulfonate, triethanolamine linear dodecylbenzenesulfonate, linear dodecylbenzenesulfonic acid, etc. Alkylbenzene sulfonate, N-
Monosodium lauroyl glutamate, disodium N-stearoyl glutamate, N-myristoyl-L
-N-acyl glutamate such as monosodium glutamate, higher fatty acid ester sulfate such as hydrogenated coconut oil fatty acid glycerin sodium sulfate, sulfated oil such as funnel oil, POE alkyl ether carboxylic acid, POE alkyl allyl ether carboxylate, α-olefin sulfonate, higher fatty acid ester sulfonate, secondary alcohol sulfate ester salt, higher fatty acid alkylolamide sulfate ester salt, lauroyl monoethanolamide sodium succinate, N-palmitoyl aspartate ditriethanolamine, sodium caseinate, etc. Anionic surfactants; alkyl trimethyl ammonium salts such as stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride Alkylpyridinium salts, such as alkyl dimethylammonium salts, poly (N, N'-dimethyl-3,5-methylenepiperidinium chloride), cetylpyridinium chloride, alkyl quaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoxy Cationic surfactants such as norinium salts, dialkylmorphonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, benzethonium chloride;
2-Undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc., imidazoline-based amphoteric interface Amphoteric surfactants such as activators, betaine-based surfactants such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaines, alkyl betaines, amidobetaines, sulfobetaines; sorbitan Monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate,
Sorbitan fatty acid esters such as sorbitan trioleate, penta-2-ethylhexyl diglycerol sorbitan, tetra-2-ethylhexyl diglycerol sorbitan, mono cottonseed oil fatty acid glycerin, monoerucic acid glycerin, sesquioleate glycerin, monostearate glycerin, α , α'-glyceryl pyroglutamate oleate, glycerol monostearate glycerin polyglycerin fatty acids such as malic acid, propylene glycol fatty acid esters such as propylene glycol monostearate, hydrogenated castor oil derivative, glycerin alkyl ether, polyoxyethylene Lipophilic nonionic surfactant such as methylpolysiloxane copolymer; PO
E sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, PO
POE sorbitan fatty acid esters such as E-sorbitan tetraoleate, POE-sorbit monolaurate, POE-sorbit monooleate, POE-sorbit pentaoleate, POE-sorbit monostearate, and other POE sorbit fatty acid esters, PO
POE glycerin fatty acid esters such as E-glycerin monostearate, POE-glycerin monoisostearate, POE-glycerin triisostearate, P
OE monooleate, POE distearate, POE monodioleate, POE fatty acid esters such as ethylene glycol distearate, POE lauryl ether,
POE oleyl ether, POE stearyl ether,
POE alkyl ethers such as POE behenyl ether, POE 2-octyldodecyl ether, POE cholestanol ether, POE octyl phenyl ether,
POE alkyl phenyl ethers such as POE nonyl phenyl ether and POE dinonyl phenyl ether, Pluronic types such as Bourronic, POE / POP cetyl ether, POE / POP 2-decyl tetradecyl ether, POE / POP monobutyl ether, POE
・ POE hydrogenated lanolin, POE / POP alkyl ethers such as POE / POP glycerin ether, tetra POE / tetra POP ethylenediamine condensates such as Tetronic, POE castor oil, POE hydrogenated castor oil, PO
E hydrogenated castor oil monoisostearate, POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearate diester, PO
E hydrogenated castor oil POE castor oil such as maleic acid hydrogenated castor oil derivative, POE beeswax lanolin derivative such as POE sorbit beeswax, alkanol amide such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, POE propylene glycol Fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid ester, PO
E Nonylphenyl formaldehyde condensates, hydrophilic nonionic surfactants such as alkylethoxydimethylamine oxide, trioleylphosphoric acid, etc .; preservatives such as ethylparaben, butylparaben; arabia gum, tragacanth gum, galactan, guar gum, carob gum, karaya gum, carrageenan , Pectin, agar, quince seed (quince), arge colloid (cassius extract),
Starch (rice, corn, potato, wheat), plant-based macromolecules such as glycyrrhizinate, microbial-based macromolecules such as xanthan gum, dextran, succinoglucan, and vullan, collagen, casein, albumin,
Natural water-soluble polymers such as animal polymers such as gelatin; starch-based polymers such as carboxymethyl starch and methyl hydroxypropyl starch Methyl cellulose, nitrocellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, sodium cellulose sulfate, hydroxy Propyl cellulose,
Cellulosic polymers such as sodium carboxymethyl cellulose (CMC), crystalline cellulose, and cellulose powder,
Semi-synthetic water-soluble polymers such as alginic acid-based polymers such as sodium alginate and propylene glycol alginate; vinyl-based polymers such as polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, carboxyvinyl polymer (Carbopol), and alkyl-modified carboxyvinyl polymer. Polymer, polyethylene glycol 2
Polymers such as 000, 4000, 6000, polyoxyethylene-polyoxypropylene copolymer copolymers, sodium polyacrylate, polyethyl acrylate, polyacrylamide and other acrylic polymers, polyethyleneimine, Synthetic water-soluble polymer such as cationic polymer; bentonite, silicic acid A1Mg
(Veegum), laponite, hectorite, inorganic water-soluble polymers such as silicic acid; gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin,
Gelatin, sodium pectate, sodium alginate, methylcellulose, ethylcellulose, CMC, hydroxyethylcellulose, hydroxypropylcellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonium sulfate. Thickeners such as cellulose, xanthan gum, magnesium aluminum silicate, bentonite, hectorite; talc, carion, mica, sericite, muscovite, phlogopite, synthetic mica, phlogopite, biotite, lithia mica, Permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tan Sten acid metal salt, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (calcined gypsum), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, metal soap (zinc myristate, calcium palmitate,
Aluminum stearate), inorganic powder such as boron nitride, polyamide resin powder (nylon powder), polyethylene powder, polymethylmethacrylate powder, polystyrene powder, copolymer resin powder of styrene and acrylic acid, benzoguanamine resin powder, polytetrafluorocarbon Powder components such as organic powders such as ethylene oxide and cellulose powder; inorganic white pigments such as titanium dioxide and zinc oxide; inorganic red pigments such as iron oxide (red iron oxide) and iron titanate; inorganic brown such as γ-iron oxide. -Based pigments, inorganic yellow pigments such as yellow iron oxide and loess, inorganic black pigments such as black iron oxide, carbon black and low order titanium oxide, inorganic purple pigments such as mango violet and cobalt violet, chromium oxide, chromium hydroxide , Inorganic green pigments such as cobalt titanate, inorganic blue pigments such as ultramarine blue and navy blue,
Titanium oxide coated mica, titanium oxide coated bismuth oxychloride, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, pearl pigments such as fish scale foil, metal powder pigments such as aluminum powder, copper powder, red 201, red 202
No., Red No. 204, Red No. 205, Red No. 220, Red No. 226, Red No. 228, Red No. 405, Orange No. 203
No. 204, Orange No. 204, Yellow No. 205, Yellow No. 401 and Blue No. 404 and other organic pigments, Red No. 3, Red No. 104,
Red 106, Red 227, Red 230, Red 40
No. 1, Red No. 505, Orange No. 205, Yellow No. 4, Yellow 5
No., Yellow No. 202, Yellow No. 203, Green No. 3, Blue No. 1, etc., organic pigments such as zirconium, barium or aluminum lake, natural pigments such as chlorophyll, β-caroline, etc., titanium yellow, cursamine, safflower red etc. Coloring agents and the like; further, fragrances, water, alcohols and the like can be appropriately added to the external preparation for skin of the present invention as necessary. The specific formulation of the external preparation for skin of the present invention will be described in Examples described later.
【0037】[0037]
【実施例】次に、本発明を実施例等により、さらに具体
的に説明する。ただし、これにより、本発明の技術的範
囲が限定解釈されるものではない。なお、以下に重量%
とあるのは、全て皮膚外用剤全体に対する重量%を意味
する。EXAMPLES Next, the present invention will be described more specifically by way of examples. However, this does not limit the technical scope of the present invention. In addition, the following weight%
The term "all" means% by weight based on the whole skin external preparation.
【0038】まず、後述する実施例における本発明皮膚
外用剤の評価法について説明する。肌荒れ防止試験
健常人男性の背部の皮膚を3%のドデシル硫酸ナトリウ
ム水溶液で処理し、肌荒れを人為的に惹起した。上記処
理から2時間後、各試料を20μl 惹起した肌荒れ部分
に塗布した。これを5日間繰り返し、6日目に目視によ
り肌荒れの状態を観察し、第1表の基準に従って採点し
た。この評点が高い程、肌荒れ改善効果に優れているこ
とを示す。First, the evaluation method of the external preparation for skin of the present invention in Examples described later will be explained. Skin Roughness Prevention Test The skin on the back of healthy men was treated with a 3% sodium dodecyl sulfate aqueous solution to artificially induce skin roughness. Two hours after the above treatment, 20 μl of each sample was applied to the rough skin area caused by 20 μl. This was repeated for 5 days, and on the 6th day, the state of rough skin was visually observed and scored according to the criteria in Table 1. The higher the score, the better the effect of improving rough skin.
【0039】 第1表 評点 評 点 の 基 準 1 広範囲の角層の乾燥,めくれ,強い紅斑を認める。 2 角層の剥離,めくれ,中程度の紅斑を認める。 3 角層の乾燥は認められるが、めくれは認められない。 弱い紅斑を認める。 4 角層の乾燥,めくれは認められないが、若干の紅斑を認める。 5 角層の乾燥,めくれ,紅斑共に認められない。 Table 1 Score Criterion Standard 1 A wide range of horny layer dryness, swelling and strong erythema are observed. 2 Exfoliation of the stratum corneum, swelling, and moderate erythema are observed. 3 Dryness of the stratum corneum is observed, but no curling is observed. Weak erythema. 4 Dryness and turning of the stratum corneum are not observed, but some erythema is observed. 5 Dryness, swelling and erythema of the stratum corneum are not observed.
【0040】被験男性は、各群10名とし、この10人
の評点の平均値を基に、各試料の肌荒れ改善効果を判定
した。There were 10 test males in each group, and the rough skin improving effect of each sample was judged based on the average value of the scores of these 10 test subjects.
【0041】判定 ◎:評点の平均が4以上 ○:評点の平均が3以上4未満 △:評点の平均が2以上3未満 ×:評点の平均が2未満 Judgment ⊚: Average score is 4 or more ○: Average score is 3 or more and less than 4 Δ: Average score is 2 or more and less than 3 ×: Average score is less than 2
【0042】〔実施例1〜5〕 ローション
第2表に示す処方のローションを下記の過程を経て調製
し、その肌荒れ改善効果を検討した(同表参照)。[Examples 1 to 5] Lotions Lotions having the formulations shown in Table 2 were prepared through the following process, and their rough skin improving effects were examined (see the same table).
【0043】[0043]
【表1】第2表 [Table 1] Table 2
【0044】<製法>95%エチルアルコール,POE
(20)ラウリルエーテル及び香料を混合し、次いでこの
中にグリセリン,プロピレングリコール,クエン酸,ト
ラネキサム酸及び2−アミノエチルチオスルホン酸(比
較例においては、本発明皮膚外用剤の必須配合成分の配
合を適宜除外した。これは、以下の実施例の製法の記載
において同様である。)とを加え、さらに精製水を全重
量が100になるように必要量を添加し、混合して、所
望するローションを調製した。<Production method> 95% ethyl alcohol, POE
(20) A lauryl ether and a fragrance are mixed, and then glycerin, propylene glycol, citric acid, tranexamic acid and 2-aminoethylthiosulfonic acid are mixed therein (in the comparative example, the essential components of the skin external preparation of the present invention are blended). The above is the same as in the description of the production method of the following examples.), And a desired amount of purified water is added so that the total weight becomes 100, and the mixture is mixed with the desired amount. A lotion was prepared.
【0045】第2表において、トラネキサム酸及び2−
アミノエチルチオスルホン酸の両者を組み合わせて配合
した本実施例のローションは、様々な配合量の組合せに
おいて非常に優れた肌荒れ改善効果が認められた。これ
に対して、トラネキサム酸及び2−アミノエチルチオス
ルホン酸いずれか又は双方を配合しない比較例のローシ
ョンは、肌荒れ改善効果が上記実施例に比べて劣ること
が明らかになった。この結果、トラネキサム酸及び2−
アミノエチルチオスルホン酸を組み合わせて配合した皮
膚外用剤における、肌荒れ改善効果に対する相乗効果が
認められた。In Table 2, tranexamic acid and 2-
The lotion of this example, which was prepared by combining both aminoethylthiosulfonic acid, was found to have an extremely excellent effect of improving rough skin in the combination of various compounding amounts. On the other hand, it was revealed that the lotion of Comparative Example in which either or both of tranexamic acid and 2-aminoethylthiosulfonic acid were not mixed was inferior in the rough skin improving effect to the above Examples. As a result, tranexamic acid and 2-
A synergistic effect on the rough skin improving effect was observed in the external preparation for skin formulated by combining aminoethylthiosulfonic acid.
【0046】〔実施例6〜10〕 乳液(1)
第3表に示す処方の乳液を下記の過程を経て調製し、そ
の肌荒れ改善効果を検討した(同表参照)。Examples 6 to 10 Emulsions (1) Emulsions having the formulations shown in Table 3 were prepared through the following steps, and their rough skin improving effects were examined (see the same table).
【0047】[0047]
【表2】第3表 [Table 2] Table 3
【0048】<製法>POE(20)POP(2)セチル
アルコールエーテル,シリコーンKF96,流動パラフ
ィン,香料及び防腐剤を70℃で溶解し、この溶解物を
プロピレングリコール,グリセリン及びエチルアルコー
ルからなる78℃の水相に入れ、次いで予めイオン交換
水で溶解したカルボキシビニルポリマー,ヒドロキシプ
ロピルセルロースを70℃に加熱してこの水相に入れ、
最後に2−アミノメチルプロパノール,プラセンタリキ
ッド,トラネキサム酸及び2−アミノエチルスルフィン
酸をさらに加え、ホモミキサーで70℃で乳化し、攪拌
冷却して乳液を調製した。<Production Method> POE (20) POP (2) cetyl alcohol ether, silicone KF96, liquid paraffin, perfume and preservative are dissolved at 70 ° C., and this dissolved product is composed of propylene glycol, glycerin and ethyl alcohol at 78 ° C. Of the carboxyvinyl polymer and hydroxypropyl cellulose previously dissolved in ion-exchanged water are heated to 70 ° C. and put into this aqueous phase.
Finally, 2-aminomethylpropanol, placenta liquid, tranexamic acid and 2-aminoethylsulfinic acid were further added, and the mixture was emulsified at 70 ° C. with a homomixer and stirred to cool to prepare an emulsion.
【0049】第3表により、2−アミノエチルスルフィ
ン酸とトラネキサム酸とを組み合わせて配合した乳液に
おいても、上記実施例1〜5のローションと同様の肌荒
れ改善に対する相乗効果が認められることが明らかにな
った。よって、2−アミノエチルスルフィン酸とトラネ
キサム酸とを組み合わせて配合した皮膚外用剤における
肌荒れ改善に対する相乗効果もまた認められた。From Table 3, it is apparent that even in the emulsion containing a combination of 2-aminoethylsulfinic acid and tranexamic acid, a synergistic effect similar to the lotions of Examples 1 to 5 described above for improving rough skin is recognized. became. Therefore, a synergistic effect for improving rough skin in the external preparation for skin prepared by combining 2-aminoethylsulfinic acid and tranexamic acid in combination was also recognized.
【0050】〔実施例11〜15〕 乳液(2)
第4表に示す処方の乳液を下記の過程を経て調製し、そ
の肌荒れ改善効果を検討した(同表参照)。[Examples 11 to 15] Emulsion (2) Emulsions having the formulations shown in Table 4 were prepared through the following steps, and their rough skin improving effects were examined (see the same table).
【0051】[0051]
【表3】第4表 [Table 3] Table 4
【0052】<製法>POE(20)POP(2)セチル
アルコールエーテル,シリコーンKF96,流動パラフ
ィン,香料及び防腐剤を70℃で溶解し、この溶解物を
プロピレングリコール,グリセリン及びエチルアルコー
ルからなる78℃の水相に入れ、次いで予めイオン交換
水で溶解したカルボキシビニルポリマー,ヒドロキシプ
ロピルセルロースを70℃に加熱してこの水相に入れ、
最後に2−アミノメチルプロパノール,プラセンタリキ
ッド,トラネキサム酸、2−アミノエチルスルフィン酸
及び2−アミノエチルチオスルホン酸をさらに加え、ホ
モミキサーで70℃で乳化し、攪拌冷却して乳液を調製
した。<Production Method> POE (20) POP (2) cetyl alcohol ether, silicone KF96, liquid paraffin, perfume and preservative are dissolved at 70 ° C., and this dissolved product is composed of propylene glycol, glycerin and ethyl alcohol at 78 ° C. Of the carboxyvinyl polymer and hydroxypropyl cellulose previously dissolved in ion-exchanged water are heated to 70 ° C. and put into this aqueous phase.
Finally, 2-aminomethylpropanol, placenta liquid, tranexamic acid, 2-aminoethylsulfinic acid and 2-aminoethylthiosulfonic acid were further added, emulsified with a homomixer at 70 ° C., and cooled with stirring to prepare an emulsion.
【0053】第4表により、2−アミノエチルスルフィ
ン酸と2−アミノエチルチオスルホン酸とを組み合わせ
てトラネキサム酸と共に配合した乳液は、本発明に関わ
るアミノエチル化合物(I)のいずれか一方をトラネキ
サム酸と配合した場合と比較しても、肌荒れ改善効果が
遜色なく発揮されるが明らかになった。According to Table 4, the emulsion prepared by combining 2-aminoethylsulfinic acid and 2-aminoethylthiosulfonic acid together with tranexamic acid was prepared by adding one of the aminoethyl compounds (I) of the present invention to tranexamic acid. It was revealed that the effect of improving rough skin is comparable to that of the case of blending with acid.
【0054】以下に、種々の剤形の本発明皮膚外用剤の
配合例を実施例として説明する。なお、各皮膚外用剤と
も優れた肌荒れ改善効果を発揮した。
〔実施例16〕 栄養クリーム
重量%
ステアリン酸 2.0
ステアリルアルコール 7.0
還元ラノリン 2.0
スクワラン 5.0
オクチルドデカノール 6.0
POE(25)セチルエーテル 3.0
グリセリルモノステアレート 2.0
プロピレングリコール 5.0
1,3−ブチレングリコール 5.0
トラネキサム酸 2.0
2−アミノエチルスルフィン酸 0.5
防腐剤 適量
香料 適量
蒸留水 残部Examples of compounding the external preparation for skin of the present invention in various dosage forms will be described below as examples. In addition, each external preparation for skin exhibited an excellent effect of improving rough skin. [Example 16] Nourishing cream% by weight Stearic acid 2.0 Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane 5.0 Octyldodecanol 6.0 POE (25) cetyl ether 3.0 Glyceryl monostearate 2.0 Propylene glycol 5.0 1,3-Butylene glycol 5.0 Tranexamic acid 2.0 2-Aminoethylsulfinic acid 0.5 Preservative proper amount Perfume proper amount Distilled water balance
【0055】〈製法〉油相部を70℃に加熱混合し、次
いでトラネキサム酸及び2−アミノエチルスルフィン酸
を含む水相を70℃に加熱し、前記油相をこの水相に加
え、ホモミキサーで攪拌混合し、冷却後、所望する栄養
クリームを得た。<Production Method> The oil phase part was heated and mixed at 70 ° C., then the aqueous phase containing tranexamic acid and 2-aminoethylsulfinic acid was heated to 70 ° C., the oil phase was added to this aqueous phase, and the homomixer was added. After stirring and mixing with, and cooling, the desired nutritional cream was obtained.
【0056】 〔実施例17〕 ピールオフ型パック 重量% アルコール相 95%エタノール 10.0 POE(15)オレイルアルコールエーテル 2.0 防腐剤 適量 香料 適量 水 相 トラネキサム酸ビタミンCエステル 1.0 2−アミノエチルチオスルホン酸 0.5 ポリビニルアルコール 12.0 グリセリン 3.0 ポリエチレングリコール1500 1.0 イオン交換水 残部[Example 17] Peel-off type pack Weight% Alcohol phase 95% Ethanol 10.0 POE (15) Oleyl alcohol ether 2.0 Preservative proper amount Perfume proper amount Water phase tranexamic acid vitamin C ester 1.0 2-aminoethyl Thiosulfonic acid 0.5 Polyvinyl alcohol 12.0 Glycerin 3.0 Polyethylene glycol 1500 1.0 Deionized water balance
【0057】〈製法〉ポリビニルアルコールをイオン交
換水で70℃で攪拌・溶解させ、次いでトラネキサム酸
ビタミンCエステル、2−アミノエチルチオスルホン
酸,グリセリン及びポリエチレングリコール1500を
加え、さらにアルコール相を70℃に加熱して前記混合
物に加え、攪拌して均一に混合し、冷却して所望するピ
ールオフ型パックを得た。<Production Method> Polyvinyl alcohol was stirred and dissolved in ion-exchanged water at 70 ° C., then tranexamic acid vitamin C ester, 2-aminoethylthiosulfonic acid, glycerin and polyethylene glycol 1500 were added, and the alcohol phase was further heated to 70 ° C. The mixture was heated to 1, added to the above mixture, stirred and uniformly mixed, and cooled to obtain a desired peel-off type pack.
【0058】 〔実施例18〕 乳液(3) 重量% POE(20)POP(2)セチルアルコールエーテル 1.0 シリコーンKF96(信越化学製) 2.0 流動パラフィン 3.0 プロピレングリコール 5.0 グリセリン 2.0 エチルアルコール 15.0 カルボキシビニルポリマー 0.3 ヒドロキシプロピルセルロース 0.1 2−アミノメチルプロパノール 0.1 トラネキサム酸カリウム 0.1 2−アミノエチルスルフィン酸 0.01 防腐剤 適量 香料 適量 蒸留水 残部[0058] Example 18 Emulsion (3) weight% POE (20) POP (2) cetyl alcohol ether 1.0 Silicone KF96 (manufactured by Shin-Etsu Chemical) 2.0 Liquid paraffin 3.0 Propylene glycol 5.0 Glycerin 2.0 Ethyl alcohol 15.0 Carboxy vinyl polymer 0.3 Hydroxypropyl cellulose 0.1 2-aminomethyl propanol 0.1 Potassium tranexamate 0.1 2-aminoethylsulfinic acid 0.01 Preservative Suitable amount Fragrance suitable amount Distilled water balance
【0059】〈製法〉70℃に調製した水相に、同じく
70℃に加熱した油相を加え、ホモミキサー処理により
乳化し、この乳化物を冷却して所望の乳液を得た。<Production Method> An oil phase, which was also heated to 70 ° C., was added to the aqueous phase prepared at 70 ° C., emulsified by a homomixer treatment, and the emulsion was cooled to obtain a desired emulsion.
【0060】[0060]
【発明の効果】本発明により、肌荒れ改善効果に優れた
肌荒れ改善用皮膚外用剤が提供される。According to the present invention, the effect of improving rough skin is excellent.
An external preparation for skin for improving rough skin is provided.
フロントページの続き (56)参考文献 特開 平6−80964(JP,A) 特開 平7−126148(JP,A) 特開 平6−329621(JP,A) 特開 平6−72975(JP,A) 特開 平6−41032(JP,A) 特開 平7−206624(JP,A) 特公 昭47−1479(JP,B1) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 Continuation of the front page (56) Reference JP-A-6-80964 (JP, A) JP-A-7-126148 (JP, A) JP-A-6-329621 (JP, A) JP-A-6-72975 (JP , A) JP-A-6-41032 (JP, A) JP-A-7-206624 (JP, A) JP-B-47-1479 (JP, B1) (58) Fields investigated (Int.Cl. 7 , DB) Name) A61K 7/00-7/50
Claims (3)
荒れ改善用皮膚外用剤。 (1)式NH2CH2CH2X (I) (式中、Xは−SO2H又は−SO2SHである) で示さ
れるアミノエチル化合物の1種又は2種を、皮膚外用剤
全体の0.0001重量%以上、同1.0重量%以下。 (2)トラネキサム酸若しくはその塩類を、皮膚外用剤
全体の0.01重量%以上、同5.0重量%以下。1. A skin comprising the following components (1) and (2):
A skin external preparation for improving roughness . (1) One or two aminoethyl compounds represented by the formula NH 2 CH 2 CH 2 X (I) (wherein, X is —SO 2 H or —SO 2 SH), as a whole skin external preparation. 0.0001% by weight or more and 1.0% by weight or less. (2) The amount of tranexamic acid or a salt thereof is 0.01% by weight or more and 5.0% by weight or less based on the total amount of the external preparation for skin.
膚外用剤全体の0.001重量%以上、同0.1重量%
以下である請求項1記載の肌荒れ改善用皮膚外用剤。2. A compounding amount of the aminoethyl compound (I) is 0.001% by weight or more and 0.1% by weight or more based on the whole skin external preparation.
The external preparation for skin roughness improvement according to claim 1, which is as follows.
が、皮膚外用剤全体の0.1重量%以上、同1.0重量
%以下である請求項1又は2記載の肌荒れ改善用皮膚外
用剤。3. The skin external preparation for improving rough skin according to claim 1, wherein the content of tranexamic acid or a salt thereof is 0.1% by weight or more and 1.0% by weight or less based on the total weight of the external preparation for skin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35182395A JP3520149B2 (en) | 1995-12-27 | 1995-12-27 | External preparation for skin roughening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35182395A JP3520149B2 (en) | 1995-12-27 | 1995-12-27 | External preparation for skin roughening |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09175986A JPH09175986A (en) | 1997-07-08 |
| JP3520149B2 true JP3520149B2 (en) | 2004-04-19 |
Family
ID=18419859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP35182395A Expired - Lifetime JP3520149B2 (en) | 1995-12-27 | 1995-12-27 | External preparation for skin roughening |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3520149B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10032165A1 (en) * | 2000-07-01 | 2002-01-10 | Beiersdorf Ag | Use of physiologically tolerable sulfinic acids as antioxidant or free radical scavenger in cosmetic or dermatological preparations |
| JP4518367B2 (en) * | 2002-03-25 | 2010-08-04 | 株式会社資生堂 | Pore reducing agent |
| JP2007230919A (en) * | 2006-03-01 | 2007-09-13 | Ki Pharma Kk | Bleaching agent |
| CN103172528B (en) * | 2011-12-23 | 2014-10-08 | 烟台万润精细化工股份有限公司 | Tranexamic acid preparation method |
| JP7815002B2 (en) * | 2022-03-24 | 2026-02-17 | 株式会社ファンケル | FABP5 production inhibitor |
-
1995
- 1995-12-27 JP JP35182395A patent/JP3520149B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09175986A (en) | 1997-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3542665B2 (en) | Anti-aging skin external preparation, collagen cross-linking inhibition skin external preparation and anti-ultraviolet skin external preparation | |
| JP3537622B2 (en) | UV absorbing composition | |
| JPH09255526A (en) | Anti-aging cosmetics | |
| US20060099161A1 (en) | Skin preparations for external use | |
| WO2001045665A1 (en) | Skin preparations for external use | |
| JP2000219607A (en) | Composition for external use | |
| JPWO2003026698A1 (en) | Skin preparation | |
| JP3495217B2 (en) | Collagen production promoter | |
| JPH11335235A (en) | Anti-aging agent | |
| JPH1160436A (en) | Cosmetic for improving chapped skin | |
| JP3520149B2 (en) | External preparation for skin roughening | |
| JPH11246425A (en) | Lipid degradation promoter and skin external preparation for slimming | |
| JPH09136823A (en) | Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin | |
| JPH09136822A (en) | Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin | |
| JP3459856B2 (en) | External preparation for skin | |
| JP3459857B2 (en) | External preparation for skin | |
| JP7507604B2 (en) | Cosmetics | |
| JPH07196443A (en) | External agent for skin | |
| JPH09249550A (en) | Skin preparation for external use | |
| JPH1160435A (en) | Cosmetic for improving chapped skin | |
| JPH09136824A (en) | Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin | |
| JPH10114642A (en) | Skin preparation for external use | |
| JPH1053516A (en) | Aging resistant and collagen crosslinking preventing skin lotion | |
| JPH11335234A (en) | Hyaluronic acid synthesis promoter and antiaging skin lotion | |
| JP7037780B2 (en) | Whitening agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20030812 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040106 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040202 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090206 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100206 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110206 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110206 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120206 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120206 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130206 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140206 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |